menu toggle
Contact Us
About us
Who we are
Our global reach
Gallery of innovation
Expertise
Why Xcenda?
Areas of expertise
Solutions
Commercialization solutions
Innovative field solutions
Health economics & outcomes research
Reimbursement & policy insights
Real-world evidence
FormularyDecisions
Value and access communications
Global market access consulting
Product launch and commercialization
Market research and advisor networks
Training & learning solutions
Manufacturer solutions from AmerisourceBergen
Our people
Our team
Insights
Insights home
Health Policy Weekly archive
HTA Quarterly archive
Careers
Careers
Life at Xcenda
Student programs
Search for jobs
The AmerisourceBergen network
News and events
Locations
Subscribe to newsletters
Contact us
LinkedIn
X
Instagram
About us
Who we are
Our global reach
Gallery of innovation
Expertise
Why Xcenda?
Areas of expertise
Solutions
Commercialization solutions
Innovative field solutions
Health economics & outcomes research
Reimbursement & policy insights
Real-world evidence
FormularyDecisions
Value and access communications
Global market access consulting
Product launch and commercialization
Market research and advisor networks
Training & learning solutions
Manufacturer solutions from AmerisourceBergen
Our people
Our team
Insights
Insights home
Health Policy Weekly archive
HTA Quarterly archive
Careers
Careers
Life at Xcenda
Student programs
Search for jobs
The AmerisourceBergen network
News and events
Locations
Subscribe to newsletters
Contact us
LinkedIn
X
Instagram
Insights
Filter By
All Topics
340B
Advocacy
Affordability
Analytics
Biosimilars
Business performance
Cell and gene therapy
Clinical trial logistics
Commercial supply chain
Commercialization
Consulting
COVID-19
Data
Direct-to-patient
Distribution
Engagement
Field Support
Financial management
Formulary solutions
Health equity
Innovation
Legislation
Managed care
Market access
Marketing
Medication adherence
Medication therapy management
Oncology
Orphan drugs
Our role in healthcare
Patient care
Patient support services
Policy
Population health management
Product access
Quality
Regulatory
Reimbursement
Research
Specialty pharmacy
Technology
Value-based care
Sort By
Date (Newest to Oldest)
Date (Oldest to Newest)
Title (A-Z)
Title (Z-A)
Filter
AmerisourceBergen
Work worth doing: Innovative field solutions
AmerisourceBergen
December 2023
Manufacturers
Essential skills for outsourced field solutions teams
AmerisourceBergen
November 2023
Manufacturers
Recap AMCP 2023: Our thought leadership in action
Xcenda
March 2023
Manufacturers
The essential guide to drug commercialization
AmerisourceBergen
February 2023
Manufacturers
Acceleration of innovation in healthcare delivery
Teri Burnell, PharmD; Myra Reinhardt
Biopharma Services
November 2022
The impact of the Build Back Better Act (BBBA) on rare disease innovation
Xcenda
December 2021
HTA Quarterly | Winter 2021
Xcenda
November 2021
ASCVD needs innovation
Xcenda
November 2021
Manufacturers
Navigating the payer landscape for digital therapeutics
Lash Group
June 2021
Manufacturers
Work worth doing: FormularyDecisions
Laurie Fazio
Xcenda
May 2021
Manufacturers
Ebook: Strategic partnerships for unlocking product potential
AmerisourceBergen
April 2021
